Human induced pluripotent stem cell-derived dopaminergic neurons release alpha-synuclein through neuronal activity

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Lewy body diseases, such as Parkinson's disease (PD), involve the intercellular spread of alpha-synuclein (αSyn).
• Understanding the mechanisms of αSyn transmission is critical for developing effective treatments for neurodegenerative disorders.
• Human induced pluripotent stem cell-derived dopaminergic neurons offer a valuable model for studying PD pathophysiology.

Purpose of the Study:

• To investigate the influence of neuronal activity on αSyn release from dopaminergic neurons.
• To determine if enhanced or suppressed neuronal activity affects αSyn secretion.
• To explore potential therapeutic targets related to αSyn transmission in PD.

Main Methods:

• Utilized human induced pluripotent stem cell-derived dopaminergic neurons, including those with a PD-associated αSyn gene mutation.
• Employed pharmacological agents (bicuculline, cyanquixaline) to modulate neuronal activity.
• Applied optogenetic stimulation to precisely control neuronal firing and assess αSyn release.

Main Results:

• Increased neuronal activity, induced by bicuculline or optogenetics, significantly enhanced αSyn release.
• Suppression of neuronal activity using cyanquixaline led to reduced αSyn secretion.
• These results confirm a direct correlation between neuronal activity levels and αSyn transmission.

Conclusions:

• Neuronal activity plays a pivotal role in the release and intercellular transmission of αSyn.
• Modulating neuronal activity presents a promising therapeutic avenue for mitigating Lewy body disease progression.
• This research advances the understanding of PD pathogenesis and offers new strategies for intervention.